Source: Reuters Oct 4 (Reuters) – A recently recalled batch of Glucagon Emergency Kits, Eli Lilly and Co’s (LLY.N) therapy for diabetic patients in crisis, was manufactured at...
Source: Reuters Sept 29 (Reuters) – AstraZeneca (AZN.L) will take full control of Caelum Biosciences in a deal worth up to $500 million, the drugmaker said on Wednesday,...
